NursesPrint Go Premium
ATI Pharmacology

ATI RN

ATI Pharmacology

Difficulty: Medium Average Score: 74% Practice

A 29-year-old man with spinal cord injury and with chronic gastric immotility syndrome has failed therapy with numerous cholinoimimetic agents. He has begun on therapy with physostigmine. Unfortunately, a supratherapeutic dose is administered to the patient. Which of the following effects must the treating physician be aware of?

Related Questions

View all